Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Source: 
Motley Fool
snippet: 
  • It crushed analyst estimates on both the top and bottom lines.
  • This, despite significant erosion in both metrics.